Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.
Pharmanex Awarded Patent on BioGinkgo 27/7
April 1, 2001
1 Min Read
Pharmanex Awarded Patent on BioGinkgo 27/7
SAN FRANCISCO--Pharmanex in January was issued a patent (No. 6,174,531) on its BioGinkgo® 27/7 ginkgo ingredient. The patent covers the preparation method for the product as well as product composition.
The extraction process covered by the patent yields increased amounts of terpene lactones and ginkgolide B. Another process is used for removing ginkgolic acids. More information is available at www.pharmanex.com.
You May Also Like